StreetAlpha
13F holdings · Q3 2026

Gagnon Advisors

New York, NY · files as Gagnon Advisors, LLC
Know the moment Gagnon Advisors filesYou follow Gagnon Advisors An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 5, 2026Next filing due Feb 15, 2027CIK 1599466

Gagnon Advisors reported 24 stocks worth $182M in its 13F filing for Q3 2026, filed Nov 5, 2026. Its largest holdings are CDNA (10.2%), EPD (6.7%) and WGS (6.5%). Compared with Q2 2026, the fund opened new positions in NVGS, BKD and BV, added to BL, OSUR and QDEL, trimmed CDNA and WGS and sold out of HZO and BYND.

Latest filing: what Gagnon Advisors did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new5 added2 trimmed2 sold outBought about $22.9M · sold about $21.8M
New 4
Added 5
Trimmed 2
  • CDNA−$16.9M−48%
  • WGS−$1.1M−8%
Sold out 2

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$182M+20.5% vs last quarter
Stocks held244 new · 2 sold out
Top 5 weight35.7%fairly concentrated
Turnover25%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
CDNA
Caredx Inc
$18.6M10.2%287K−260K (−48%)8 of 8
2
EPD
Enterprise Products
$12.1M6.7%340KNo change8 of 8
3
WGS
Genedx Holdings Corp
$11.8M6.5%163K−15K (−8%)8 of 8
4
FIVN
FIVE9 Inc
$11.4M6.3%336KNo change8 of 8
5
HNGE
Hinge Health Inc
$11M6.0%113KNo change3 of 8
6
EQIX
Equinix Inc
$10.8M6.0%11KNo change8 of 8
7
BIOLIFE SOLUTIONS INC
$10.7M5.8%274KNo change8 of 8
8
FRSH
Freshworks Inc
$9.9M5.5%776KNo change8 of 8
9
AMRC
Ameresco Inc
$9.8M5.4%473KNo change8 of 8
10
PCRX
Pacira Biosciences Inc
$8.8M4.8%353KNo change8 of 8
🔒 14 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
HZO
Marinemax Inc
$3.6M97K
BYND
Beyond Meat Inc
$292K389K

Reported value

last 8 quarters
$156MQ4 '24
$142MQ1 '25
$149MQ2 '25
$162MQ3 '25
$158MQ4 '25
$136MQ1 '26
$151MQ2 '26
$182MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 5, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Gagnon Advisors 13F FAQ

What does Gagnon Advisors own?

Gagnon Advisors reported 24 stocks worth $182M in its 13F filing for Q3 2026, filed Nov 5, 2026. Its largest holdings are CDNA (10.2%), EPD (6.7%) and WGS (6.5%). The table above lists every position in the filing (the top 10 without an account).

What did Gagnon Advisors buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 5 added to, 2 trimmed and 2 sold out. New positions include NVGS, BKD and BV. It sold all of HZO and BYND.

When will Gagnon Advisors file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Gagnon Advisors's portfolio worth?

The Q3 2026 filing reports $182M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.